Region: Italy

Private practice leadership roundtable

Featured in Special Report 2021 Q3: IP leadership - what it is and why it matters

09 September 2021

Sisvel, Xiaomi reach settlement over cellular patents

Deal ends litigation in China and Europe, with Xiaomi gaining rights to mobile patents owned by Sisvel and Mitsubishi Electric

30 June 2021

European Super League could face domain and trademark issues as backlash to football revolution grows

Analysis by the team at IAM's sister publication World Trademark Review finds the 12 clubs involved are IP-savvy, but vulnerable to brand risk

19 April 2021

SCOTUS appeal a reminder that small IP mistakes can have disastrous consequences

Invalidation of mistranslated US patent is against TRIPS requirements, argues Swiss company that lost ANDA litigation as a result of the decision

11 March 2021

Mitsubishi Electric notches Chinese validity wins in wireless pool fight

A portfolio of 3G patents from a Sisvel pool is ruled valid by patent office ahead of key FRAND cases

02 November 2020

Dividing UPC life sciences division would be a mistake, warns Bracco IP strategy chief

Splitting what should have been the London court’s competencies between Paris and Munich must only be a temporary fix, says Francesco Macchetta

06 October 2020

Sisvel and u-blox eye future cooperation after settlement announcement

Auto supplier and licensing specialist end FRAND litigation and agree “multi-year solution”

28 September 2020

EPO plant patent decision imperils businesses like ours, says Bayer’s head of IP

Joerg Thomaier tells IAM that the Enlarged Board of Appeal got it wrong in a recent controversial ruling, but says the case is now closed and companies have to learn to live with it

22 September 2020

Oppo waging broad validity campaigns against Sharp, Sisvel in China

Chinese smartphone maker Oppo recently knocked out one patent held by each firm, but sources say there are more cases to come

28 August 2020

How compulsory licensing regimes in key European jurisdictions might respond to a covid-19 cure

Experts in France, Germany, Italy, Spain and the UK explain how their jurisdictions are set up to apply march-in rights should viable coronavirus treatments emerge

14 August 2020

Get unlimited access to all IAM content